Abstract
Although obesity-related deficiency of adipokines is known to contribute to increased psoriasis severity and decreased clinical response to interventions, the mechanism by which it exacerbates psoriasis is poorly defined. We hypothesized that adipokines suppress the activation of innate immune responses in keratinocytes and skin-resident Th17/γδ T cells. In preliminary studies, we confirmed that diet-induced obese (DIO) mice had significantly lower serum adiponectin levels than lean mice when subjected to topical imiquimod (IMQ) treatments to induce the psoriasis-like disease, supporting the use of this model for studies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
